ClinConnect ClinConnect Logo
Search / Trial NCT07091565

Supporting Sexual Recovery in Women With Bladder Cancer

Launched by KING'S COLLEGE LONDON · Jul 21, 2025

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Bladder Cancer Transitional Cell Carcinoma Radical Cystectomy Anterior Exenteration Exenteration Sexual Function Women Female Gynaecological Organs

ClinConnect Summary

Background \& Aims Bladder cancer is one of the top ten cancers in the UK. In women, it can be more aggressive, meaning it can be more harmful. Bladder cancer often needs invasive treatment or procedures such as bladder removal. This can cause problems with a woman's sexual well-being and recovery.

There are different types of bladder cancer, and each requires a different treatment. In high-risk types, a more intensive treatment is required. The patient may need to have their bladder removed. The bladder is replaced with an alternative option for urine drainage such as a bag on the skin. I...

Gender

FEMALE

Eligibility criteria

  • Patient Inclusion
  • All women and other patients with a clitoris, vagina, neo-vagina or neo-clitoris
  • Have a diagnosis of BCa-any grade/stage and have had a cystectomy (bladder removal)
  • At least 6 months after cystectomy
  • \>/ 18 years old
  • Written informed consent.
  • HCP Inclusion
  • All those working directly within a bladder cancer speciality
  • Professional registration
  • Written informed consent
  • Patient Exclusion
  • Poor command of the English language to the extent that the researcher judges this to critically undermine the ability to achieve the objectives of the interview.
  • A judgement by the researcher or the individual's clinician, based on either clinical appraisal (capacity assessment) or review of the individual's medical notes, that the individual has a cognitive functioning impairment that would interfere with ability to understand and complete the interview.
  • Documentation in the accessible medical notes of a psychiatric condition that would hamper participation in interview.
  • A judgement by the researcher or the individual's clinician, based on either clinical appraisal or review of the individual's medical notes, that the individual is too ill to participate; or is ill enough that participation would produce an unreasonable burden on that individual.
  • Aged \<18 years.
  • HCP Exclusion:
  • -Those without professional registration

About King's College London

King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported